Leukopenia


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

leukopenia

[‚lü·kō′pē·nē·ə]
(medicine)
A reduction in the leukocyte count to values below the normal limit. Also known as leukocytopenia.

Leukopenia

 

leukocytopenia, a decrease in the absolute number of leukocytes in the peripheral blood.

Leukopenia is usually caused by a redistribution of blood that occurs with certain physiological conditions, such as with increased tonus in the vagus nerve, with diminished function in the adrenal cortex and in the sympathetic nervous system, after a hot bath, and with starvation. Cases are known of familial, “constitutional” leukopenia. Leukopenia may develop after infection or repeated blood transfusion (autoimmune and isoimmune leukopenias) or after taking certain drugs (sulfanilamides, Amidopyrine). It may have diagnostic significance with influenza, kala-azar, typhoid fever, brucellosis, malaria, and certain other diseases. Severe leukopenia develops in the presence of fatty degeneration of the bone marrow, an aplasia that arises as an independent disease (aplastic anemia), or as a result of severe intoxication (benzene, some drugs) or ionizing radiation.

REFERENCES

Istamanova, T. S., and V. A. Almazov. Leikopenii i agranulotsitozy. Leningrad, 1961.

G. A. ALEKSEEV

References in periodicals archive ?
The 2 patients reported here had relatively mild illness, and 1 did not have leukopenia. Therefore, further epidemiologic and clinical research is needed to clarify the epidemiology, geographic distribution, and transmission dynamics of SFTSV in Vietnam and other areas of Southeast Asia.
Electronic medical records from the same health care system as that used by the patients with confirmed cases were searched using the International Classification of Diseases, Tenth Revision codes for fever and leukopenia to identify possible additional cases.
Interestingly, the proportion of patients with neutropenia was 49% (n=25) out of the total sample of patients with sepsis and leukopenia (n=51).
Thrombocytopenia, neutropenia, anemia, leukopenia, fatigue, hemorrhage, pyrexia, nausea, headache, febrile neutropenia, increased transaminases, abdominal pain, increased gamma-glutamyltransferase, and hyperbilirubinemia.
We identified thirty-two children with leukopenia, that is, white blood cell (WBC) counts below 4.0 x [10.sup.3]/mL, followed by peripheral neutropenia (neutrophils < 1.5 x [10.sup.3]/mL), whereas 57 children with normal hematological parameters were matched as control group by age and the same geographic origin.
The rates of disease flares, active lupus nephritis, thrombocytopenia, leukopenia, LAC positivity, aCL antibody positivity, and hypocomplementemia were higher in mothers with PIH than those without (Table 5).
Remaining had WBC count abnormalities, among that leucocytosis (13.73%) were seen > leukopenia (9.80%).
Systemic damages evaluated in our study included pulmonary interstitial fibrosis, pulmonary bullae, liver function damage, PBC, renal tubular acidosis, neural lesions, leukopenia, anemia, thrombocytopenia, and arthritis.
Complete blood count was significant for leukopenia with a WBC count of 2,300 per [mm.sup.3] and thrombocytopenia to 131,000 platelets per [mm.sup.3].
Laboratory evaluation revealed the presence of transaminitis, leukopenia, and an elevated alkaline phosphatase level.
Throughout the admission, the only consistent features following 9 days of olanzapine treatment were thrombocytopenia, leukopenia, and neutropenia.